 Mark Mennemeier
Concepts (210)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcranial Magnetic Stimulation | 10 | 2018 | 72 | 2.090 |
Why?
| | Tinnitus | 9 | 2017 | 64 | 1.940 |
Why?
| | Attention | 19 | 2020 | 169 | 1.480 |
Why?
| | Perceptual Disorders | 8 | 2011 | 14 | 1.290 |
Why?
| | Stroke | 6 | 2014 | 520 | 0.790 |
Why?
| | Psychomotor Performance | 9 | 2007 | 126 | 0.750 |
Why?
| | Neuropsychological Tests | 12 | 2012 | 345 | 0.750 |
Why?
| | Functional Laterality | 8 | 2012 | 92 | 0.720 |
Why?
| | Size Perception | 4 | 2005 | 5 | 0.550 |
Why?
| | Reaction Time | 9 | 2017 | 207 | 0.530 |
Why?
| | Temporal Lobe | 3 | 2012 | 70 | 0.490 |
Why?
| | Brain Injuries | 3 | 2014 | 160 | 0.480 |
Why?
| | Dominance, Cerebral | 7 | 2008 | 26 | 0.470 |
Why?
| | Peroneal Nerve | 1 | 2014 | 6 | 0.440 |
Why?
| | Transcutaneous Electric Nerve Stimulation | 1 | 2014 | 11 | 0.430 |
Why?
| | Cold Temperature | 2 | 2011 | 54 | 0.420 |
Why?
| | Patient Admission | 1 | 2014 | 81 | 0.420 |
Why?
| | Gait Disorders, Neurologic | 1 | 2014 | 38 | 0.410 |
Why?
| | Regional Blood Flow | 3 | 2011 | 112 | 0.400 |
Why?
| | Brain | 4 | 2012 | 1350 | 0.400 |
Why?
| | Positron-Emission Tomography | 4 | 2011 | 298 | 0.380 |
Why?
| | Visual Fields | 5 | 2006 | 41 | 0.380 |
Why?
| | Hypnosis | 1 | 2012 | 6 | 0.370 |
Why?
| | Orientation | 6 | 2005 | 21 | 0.370 |
Why?
| | Space Perception | 4 | 2003 | 16 | 0.340 |
Why?
| | Evoked Potentials, Somatosensory | 1 | 2011 | 11 | 0.340 |
Why?
| | Middle Aged | 24 | 2018 | 13419 | 0.330 |
Why?
| | Adult | 25 | 2020 | 14534 | 0.320 |
Why?
| | Aged | 20 | 2018 | 10429 | 0.320 |
Why?
| | Male | 30 | 2018 | 27435 | 0.310 |
Why?
| | Cognition Disorders | 1 | 2011 | 199 | 0.310 |
Why?
| | Visual Perception | 6 | 2011 | 40 | 0.310 |
Why?
| | Cerebral Infarction | 4 | 2006 | 37 | 0.300 |
Why?
| | Female | 31 | 2018 | 28782 | 0.290 |
Why?
| | Humans | 43 | 2020 | 53230 | 0.290 |
Why?
| | Blood Glucose | 1 | 2011 | 490 | 0.280 |
Why?
| | Cognition | 5 | 2018 | 346 | 0.260 |
Why?
| | Hospitalization | 1 | 2011 | 749 | 0.250 |
Why?
| | Cross-Over Studies | 5 | 2018 | 241 | 0.240 |
Why?
| | Pattern Recognition, Visual | 4 | 2004 | 19 | 0.240 |
Why?
| | Automobile Driving | 2 | 2002 | 27 | 0.230 |
Why?
| | Psychophysics | 2 | 2003 | 5 | 0.200 |
Why?
| | Pilot Projects | 4 | 2018 | 726 | 0.190 |
Why?
| | Brain Diseases | 2 | 1994 | 85 | 0.190 |
Why?
| | Illusions | 1 | 2002 | 1 | 0.180 |
Why?
| | Brain Damage, Chronic | 3 | 1997 | 14 | 0.180 |
Why?
| | Arousal | 4 | 2011 | 104 | 0.180 |
Why?
| | Hemiplegia | 3 | 2012 | 12 | 0.180 |
Why?
| | Vision Disorders | 1 | 2002 | 61 | 0.180 |
Why?
| | Caffeine | 2 | 2020 | 64 | 0.170 |
Why?
| | Prefrontal Cortex | 4 | 2013 | 85 | 0.170 |
Why?
| | Treatment Outcome | 6 | 2018 | 5595 | 0.170 |
Why?
| | Central Nervous System Stimulants | 2 | 2020 | 201 | 0.170 |
Why?
| | Thalamic Nuclei | 2 | 1997 | 7 | 0.160 |
Why?
| | Disorders of Excessive Somnolence | 1 | 2020 | 7 | 0.160 |
Why?
| | Cerebral Cortex | 4 | 2006 | 194 | 0.150 |
Why?
| | Sensory Thresholds | 3 | 2015 | 15 | 0.140 |
Why?
| | Pain Measurement | 2 | 2011 | 259 | 0.140 |
Why?
| | Psychometrics | 2 | 2012 | 244 | 0.140 |
Why?
| | Young Adult | 6 | 2017 | 4511 | 0.140 |
Why?
| | Basal Ganglia | 2 | 1997 | 25 | 0.140 |
Why?
| | Alpinia | 1 | 2017 | 1 | 0.140 |
Why?
| | Verbal Behavior | 2 | 1997 | 36 | 0.140 |
Why?
| | Deglutition | 2 | 2015 | 45 | 0.130 |
Why?
| | Plant Preparations | 1 | 2017 | 41 | 0.130 |
Why?
| | Apathy | 1 | 2018 | 41 | 0.130 |
Why?
| | Aged, 80 and over | 4 | 2011 | 3494 | 0.120 |
Why?
| | Double-Blind Method | 4 | 2020 | 729 | 0.120 |
Why?
| | Oropharynx | 1 | 2015 | 13 | 0.110 |
Why?
| | Foot | 2 | 2011 | 41 | 0.110 |
Why?
| | Mouth | 1 | 2015 | 36 | 0.110 |
Why?
| | Proprioception | 1 | 1994 | 7 | 0.110 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 61 | 0.110 |
Why?
| | Locomotion | 1 | 2014 | 79 | 0.110 |
Why?
| | Electromyography | 1 | 2014 | 128 | 0.100 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2017 | 630 | 0.100 |
Why?
| | Biofeedback, Psychology | 1 | 2013 | 18 | 0.100 |
Why?
| | Fiber Optic Technology | 1 | 2013 | 14 | 0.100 |
Why?
| | Electric Stimulation | 1 | 2013 | 103 | 0.100 |
Why?
| | Research Design | 2 | 2013 | 373 | 0.100 |
Why?
| | Anesthetics | 1 | 2013 | 38 | 0.100 |
Why?
| | Visual Acuity | 2 | 2006 | 155 | 0.100 |
Why?
| | Parietal Lobe | 2 | 1992 | 26 | 0.100 |
Why?
| | Endoscopy | 1 | 2013 | 128 | 0.090 |
Why?
| | Suggestion | 1 | 2012 | 5 | 0.090 |
Why?
| | Deglutition Disorders | 1 | 2013 | 76 | 0.090 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2011 | 182 | 0.090 |
Why?
| | Personal Space | 1 | 1992 | 3 | 0.090 |
Why?
| | Spatial Behavior | 2 | 2004 | 9 | 0.090 |
Why?
| | Age Factors | 2 | 2015 | 1136 | 0.090 |
Why?
| | Adolescent | 5 | 2017 | 6907 | 0.090 |
Why?
| | Habituation, Psychophysiologic | 1 | 2011 | 33 | 0.080 |
Why?
| | Radiography | 1 | 2012 | 476 | 0.080 |
Why?
| | Language | 1 | 2012 | 147 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2006 | 1219 | 0.080 |
Why?
| | Time Factors | 3 | 2013 | 2991 | 0.080 |
Why?
| | Home Care Services | 1 | 2011 | 72 | 0.080 |
Why?
| | Decision Making | 1 | 2013 | 278 | 0.080 |
Why?
| | Feasibility Studies | 2 | 2011 | 411 | 0.080 |
Why?
| | Aging | 1 | 2015 | 714 | 0.080 |
Why?
| | Dementia | 1 | 2011 | 141 | 0.080 |
Why?
| | Clinical Trials as Topic | 1 | 2012 | 466 | 0.080 |
Why?
| | Analysis of Variance | 1 | 2011 | 547 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2011 | 598 | 0.080 |
Why?
| | Chronic Disease | 1 | 2012 | 580 | 0.080 |
Why?
| | Smoking | 1 | 2013 | 526 | 0.070 |
Why?
| | Electroencephalography | 1 | 2011 | 305 | 0.070 |
Why?
| | Cerebrovascular Disorders | 3 | 1998 | 51 | 0.070 |
Why?
| | Muscle, Skeletal | 1 | 2014 | 815 | 0.070 |
Why?
| | Equipment Safety | 1 | 2008 | 11 | 0.070 |
Why?
| | Retreatment | 1 | 2008 | 60 | 0.070 |
Why?
| | rRNA Operon | 1 | 1997 | 1 | 0.070 |
Why?
| | Secondary Prevention | 1 | 2008 | 85 | 0.070 |
Why?
| | Mycobacterium | 1 | 1997 | 28 | 0.070 |
Why?
| | Ribosomes | 1 | 1997 | 33 | 0.070 |
Why?
| | Cues | 2 | 2005 | 56 | 0.060 |
Why?
| | Sensation | 1 | 2006 | 11 | 0.060 |
Why?
| | Restraint, Physical | 1 | 2006 | 20 | 0.060 |
Why?
| | Energy Metabolism | 1 | 2008 | 324 | 0.060 |
Why?
| | Reference Values | 1 | 2006 | 311 | 0.060 |
Why?
| | Promoter Regions, Genetic | 1 | 1997 | 465 | 0.060 |
Why?
| | Quality of Life | 1 | 2011 | 902 | 0.060 |
Why?
| | Memory | 1 | 2005 | 97 | 0.060 |
Why?
| | Exercise Therapy | 1 | 2006 | 105 | 0.050 |
Why?
| | Follow-Up Studies | 4 | 2017 | 2318 | 0.050 |
Why?
| | Severity of Illness Index | 3 | 2006 | 1049 | 0.050 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 182 | 0.050 |
Why?
| | Behavior Therapy | 1 | 2006 | 185 | 0.050 |
Why?
| | Single-Blind Method | 2 | 2013 | 120 | 0.050 |
Why?
| | Contrast Sensitivity | 1 | 2002 | 6 | 0.050 |
Why?
| | Fixation, Ocular | 1 | 2002 | 12 | 0.050 |
Why?
| | Models, Psychological | 1 | 2002 | 81 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 2002 | 186 | 0.040 |
Why?
| | Algorithms | 1 | 2004 | 667 | 0.040 |
Why?
| | Hemianopsia | 1 | 2000 | 4 | 0.040 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 2 | 1997 | 53 | 0.040 |
Why?
| | Brain Mapping | 2 | 1997 | 223 | 0.040 |
Why?
| | Thalamic Diseases | 1 | 1997 | 1 | 0.030 |
Why?
| | Thinking | 1 | 1997 | 19 | 0.030 |
Why?
| | Word Association Tests | 1 | 1997 | 2 | 0.030 |
Why?
| | Speech Articulation Tests | 1 | 1997 | 2 | 0.030 |
Why?
| | Executive Function | 1 | 2018 | 78 | 0.030 |
Why?
| | Discrimination Learning | 1 | 1997 | 58 | 0.030 |
Why?
| | Fingers | 1 | 1997 | 34 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2002 | 1723 | 0.030 |
Why?
| | Thalamus | 2 | 2006 | 33 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 4 | 2007 | 1180 | 0.030 |
Why?
| | Sleep | 1 | 2017 | 195 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 2 | 2006 | 1583 | 0.030 |
Why?
| | Anxiety | 1 | 2017 | 321 | 0.030 |
Why?
| | Posture | 1 | 1994 | 65 | 0.030 |
Why?
| | Body Mass Index | 1 | 2017 | 717 | 0.030 |
Why?
| | Alzheimer Disease | 1 | 2018 | 338 | 0.030 |
Why?
| | Control Groups | 1 | 2013 | 9 | 0.030 |
Why?
| | Administration, Topical | 1 | 2013 | 62 | 0.020 |
Why?
| | Nose | 1 | 2013 | 33 | 0.020 |
Why?
| | Gambling | 1 | 2013 | 19 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2013 | 169 | 0.020 |
Why?
| | Aphasia, Wernicke | 1 | 1992 | 3 | 0.020 |
Why?
| | Impulsive Behavior | 1 | 2013 | 77 | 0.020 |
Why?
| | Reward | 1 | 2013 | 119 | 0.020 |
Why?
| | Choice Behavior | 1 | 2013 | 84 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2012 | 275 | 0.020 |
Why?
| | Motor Activity | 1 | 1992 | 227 | 0.020 |
Why?
| | Prospective Studies | 1 | 2015 | 2411 | 0.020 |
Why?
| | Mycobacterium phlei | 1 | 1997 | 1 | 0.020 |
Why?
| | Mycobacterium chelonae | 1 | 1997 | 7 | 0.020 |
Why?
| | Mycobacterium fortuitum | 1 | 1997 | 6 | 0.020 |
Why?
| | RNA, Ribosomal | 1 | 1997 | 16 | 0.020 |
Why?
| | Awareness | 2 | 2002 | 26 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 1997 | 51 | 0.020 |
Why?
| | RNA, Bacterial | 1 | 1997 | 53 | 0.020 |
Why?
| | Sequence Alignment | 1 | 1997 | 119 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 1997 | 175 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 1997 | 60 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 1997 | 145 | 0.020 |
Why?
| | RNA, Ribosomal, 16S | 1 | 1997 | 115 | 0.020 |
Why?
| | Plasmids | 1 | 1997 | 164 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 1997 | 167 | 0.020 |
Why?
| | Virulence | 1 | 1997 | 163 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 1997 | 216 | 0.020 |
Why?
| | Auditory Cortex | 1 | 2006 | 19 | 0.020 |
Why?
| | Molecular Structure | 1 | 1997 | 320 | 0.020 |
Why?
| | Base Sequence | 1 | 1997 | 620 | 0.020 |
Why?
| | Therapy, Computer-Assisted | 1 | 2006 | 33 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 1997 | 452 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 1997 | 759 | 0.020 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 1997 | 177 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 1997 | 374 | 0.020 |
Why?
| | Physical Stimulation | 1 | 2006 | 30 | 0.020 |
Why?
| | Audiometry, Evoked Response | 1 | 2006 | 7 | 0.020 |
Why?
| | Paresis | 1 | 2006 | 7 | 0.020 |
Why?
| | Task Performance and Analysis | 1 | 2006 | 52 | 0.010 |
Why?
| | Psychological Tests | 1 | 2006 | 52 | 0.010 |
Why?
| | Radiopharmaceuticals | 1 | 2006 | 198 | 0.010 |
Why?
| | Brain Stem | 1 | 2006 | 58 | 0.010 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2006 | 187 | 0.010 |
Why?
| | Evoked Potentials, Auditory | 1 | 2006 | 90 | 0.010 |
Why?
| | Arkansas | 1 | 2011 | 2068 | 0.010 |
Why?
| | Ambulatory Care Facilities | 1 | 2006 | 121 | 0.010 |
Why?
| | Benzhydryl Compounds | 1 | 2006 | 70 | 0.010 |
Why?
| | Neuroprotective Agents | 1 | 2006 | 101 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2006 | 934 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2006 | 1212 | 0.010 |
Why?
| | Accidents, Traffic | 1 | 2002 | 91 | 0.010 |
Why?
| | Random Allocation | 1 | 2002 | 284 | 0.010 |
Why?
| | Confusion | 1 | 1997 | 19 | 0.010 |
Why?
| | Distance Perception | 1 | 1994 | 3 | 0.010 |
Why?
| | Problem Solving | 1 | 1994 | 41 | 0.010 |
Why?
| | Frontal Lobe | 1 | 1992 | 46 | 0.010 |
Why?
|
|
Mennemeier's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
|